top of page
MEDICINAL ORGANIC CHEMISTRY GROUP
Funded projects
Research lines
Proteolysis-targeting chimeric technology for the development of mutant p53-based anticancer drugs
Source of Funding: Fundação para a Ciência e a Tecnologia (FCT)
Period: 2025-2027
HORIZON-TMA-MSCA-DN
Protease‐guided tumor targeting tools to revolutionize cancer diagnosis and treatment
Source of Funding: European Commission
Period: 2022-2026
COST ACTION
European COST Action CA21145 “European Network for diagnosis and treatment of antibiotic-resistant bacterial infections (EURESTOP)”
Source of Funding: European Cooperation in Science and Technology (COST) actions
Period: 2022-2026
bottom of page